Insight Molecular Diagnostics Inc. IMDX
2.50 USD +0.04 (+1.63%)
Nov 6, 2026, 12:17 PM EST
2.45 Day range 2.52
2.35 52-week range 8.51
- YTD
- -66.67%
- 1 year
- -61.54%
- Market cap
- 81.65M
- EPS (ttm)
- -1.52
- YTD return
- -66.67%
- 1-year return
- -61.54%
- Volume
- 55.91K
- Avg volume
- 245.19K
- Open
- 2.49
- Previous close
- 2.46
- Day's range
- 2.45 – 2.52
- 52-week range
- 2.35 – 8.51
5D -0.70 (-22.80%)
Financials — quick view
IMDX Revenue — quarterly 239.00K
IMDX Net income — quarterly -11.26M
IMDX EPS — quarterly -0.31
News
iMDx to Release Third Quarter Results on November 16, 2026 
iMDx Amends Chronix Merger Agreement, Replacing Ongoing 10% CNI Monitor Royalty With 10% Sale Payment Upon CNI Monitor Sale 
LUCID CAPITAL MARKETS Initiates Coverage On Insight Molecular with Buy Rating, Announces Price Target of $8 
Transcript: Insight Molecular Q2 2026 Earnings Conference Call - Insight Molecular Diagnostics To Host Virtual KOL Event On August 17 To Discuss GraftAssure Platform Leveraging Digital PCR Technology For Reliable dd-cfDNA Results In Transplanted Organ Health Monitoring
CORRECTION: Insight Molecular Q2 Adj. EPS $(0.23) Beats $(0.24) Estimate, Sales $239.000K Miss $437.500K Estimate - 12 Health Care Stocks Moving In Friday's After-Market Session
Insight Molecular Q1 2026 Earnings Call Transcript - Insight Molecular Q1 Adj. EPS $(0.28) Misses $(0.26) Estimate, Sales $32.000K Miss $300.000K Estimate
Earnings Scheduled For May 13, 2026
Your note
Sign in to keep a note on IMDX — it syncs with the Stock Master app.